• David Williams, MD

    Unlocking the Secrets of Pediatric Cancers can Help Children and Adults

    Understanding cancers of young children could also hold the key to understanding a broad range of adult cancers, David Williams, MD, writes.
    Gene Therapy Study

    Gene Therapy for “Bubble Boy” Disease Appears Effective, Safe

    A new form of gene therapy for boys with “bubble boy” disease appears to be effective and may avoid the late-developing leukemia seen in patients in pioneering gene therapy trials in Europe more than a decade ago.
    Mayor Walsh with Brain Tumor Survivor Group

    Boston Mayor Marty Walsh ‘Proud to be a Cancer Survivor’

    Boston Mayor Martin Walsh reflects on his successful fight against childhood lymphoma at Dana-Farber’s annual celebration of survivorship.
    sickle cell blood cell

    Hope Grows for Patients with Sickle Cell Disease

    Advances in research and treatment mean longer life expectancy and better managed pain for people with sickle cell disease.
    Alisha AT/RT

    Young Girl’s Cancer Fight Intersects with Researcher’s Quest

    An Irish couple brought their 3-year-old daughter to Dana-Farber/Boston Children's for treatment of her rare brain tumor. Meanwhile, research into her cancer could hold clues to many other, more common malignancies.
    Gwen

    Lives Less Ordinary: Pediatric Palliative Care

    Pediatric palliative care helps children like 11-year-old Gwen Lorimer, who has spent much of her life in and out of hospitals.
  • Ranked #1 for Cancer Care

    US News

    Rated the top pediatric
    cancer center by U.S. News & World Report

  • Innovative Treatments

    Gene Therapy Callout2 

    Through clinical trials and research, Dana-Farber/Boston Children's is at the forefront of innovative treatments, including gene therapy.

  • What Parents of Children with Cancer Should Know

    If your child has cancer, stay positive. With recent advances, the five-year survival rate is 84 percent for all childhood cancers combined, up from 61 percent in the mid-1970s.